Delhi HC orders seizure, relocation of 129 EVs from Gensol, BluSmart in fallout of loan scamThe EVs in question were hypothecated to STCI Finance by Gensol and BluSmart after the lender alleged default in loan payments and sought t...
BoI to raise Rs 400-500 crore from non-core asset saleIt could be noted that the bank has been looking to sell its stake in a few non-core assets including Star Union Dai-Ichi Life Insurance, S...
Bank of India looks to raise Rs 1,000 crore from sale of non-core assets, real estateThe bank expects to raise around Rs 800 crore through sale of its stake in non-banking finance company - STCI Finance - and in Sidbi, by th...
Bank of India to raise over Rs 600 crore by selling stake in finance companyThe bank has indicated that it has set a floor price of Rs 550 per share for its stake its 1.13 crore share.
Tourism Ministry inks MoU for certification of tour operatorsTourism Joint Secretary Suman Billa and ESOI Honorary President Steve Borgia signed the MoU in the presence of Tourism Secretary Vinod Zuts...
- State Bank of Mysore has gained 21% this year
Experts attribute the rally to a recent announcement by Sebi that eases the process for a listed company's promoters to sell their shares.
- STCI Finance acquires minority stake in Tulip Telecom
Bank of India controlled STCI Finance has acquired minority stake in Tulip Telecom for an undisclosed amount.
- StanChart completes 100 pc acquisition of UTI Securities
British banking giant Standard Chartered Bank has completed the acquisition of a 100 per cent stake in UTI Securities from Stock Trading Co...
- StanChart acquires additional 25.9% stake in securities arm
Global banking major Standard Chartered has increased its stake holding in Standard Chartered-STCI Capital Markets to 74.9 per cent by acqu...
- Buy Sterlite for target Rs 765: STCI Capital Market
STCI Capital Markets has initiated ‘buy’ on Sterlite Industries for a target price of Rs 765. The company has a substantial market share in...
- STCI puts buy on Sun Pharma; target Rs 1,732
STCI Capital Markets has initiated ‘buy’ on Sun Pharmaceuticals for a 12 month target price of Rs1,732.
- STCI Cap assigns 'underperformer' to Ranbaxy; target Rs 503
STCI Capital Markets Research has changed their recommendation to ‘underperformer’ on Ranbaxy Laboratories with a price target of Rs 503.
- STCI Cap sees highest upside in Indian Hotels
The Indian hotel industry has been relishing the good times in recent years, more specifically FY04 onwards, prior to which the 9-11 disast...
- STCI keen to operate UTISEL's commodity broking arm
Securities Trading Corporation of India is keen to operate UTI Securities Ltd's commodity broking arm if the RBI does not allow Standard Ch...
- RBI may not allow Stanchart in UTI's commodity arm
RBI may not allow Standard Chartered Mauritius Limited to pick up stake in STCI Commodities Limited, the commodity broking arm of UTI Secur...
- StanChart picks 49% in UTI Securities
Standard Chartered has entered into an agreement to acquire 49% stake in UTI Securities from the Securities Trading Corporation of India (S...
- Kuwait fund house eyes STCI stake in UTI Sec
Kuwait-based Global Investment House, a leading investment company in the Middle East with assets under management of over $6 billion, has ...